A case of artificial intelligence-enhanced diagnostics leading to heart transplantation
A case of artificial intelligence-enhanced diagnostics leading to heart transplantation
https://www.nature.com/articles/s41591-026-04454-y
Publish Date: 2026-06-22 05:59:00
Source Domain: www.nature.com
Using an unordered list, summarize the following article with between 4 and 8 key points.
Competing interests
T.J.P. owns stock in Abbott Laboratories and Baxter International, and has research support provided to his affiliated institutions from the Tianqiao & Chrissy Chen Institute, American Heart Association (awards 933452 and 23SCISA1077494) Eidos Therapeutics, Pfizer, Janssen Pharmaceuticals and Edwards Lifesciences. T.J.P. and P.E. are inventors of the AI-ECG algorithm “EchoNext” for the detection of structural heart disease. P.E. has received research support to his institution from the American Heart Association, Eidos Therapeutics, Pfizer, Janssen Pharmaceuticals, New York Academy of Medicine, Edwards Lifesciences, and owns equity in Pathway Labs. M.A.P. is supported by a grant from the NIH/NHLBI (R01HL149680). All other authors declare no competing interests.
